Formulation and Optimization of Liquisolid Compact for Enhancing Dissolution Properties of Polyphenol Stilbenoid- Resveratrol
Abstract
Resveratrol is a class II drug in the Biopharmaceutics Classification System (BCS) with poor water solubility (0.03 mg/ml) and high permeability. Liquisolid system is an innovative technique used for enhancing dissolution rate and bioavailability of poorly soluble drugs. The present study demonstrated that Resveratrol loaded SNEDDS and Liquisolid compacts were successfully developed. Ten SNEDDS formulation were formulated with different ratio oil, surfactant and co-surfactant. Out of ten formulations four were selected based on dilution and self-emulsification time. Out of four formulations F4 formulation showed smaller particle size than compared with other formulations. Characterization was done for particle size, polydispersity index and zeta potential was found to be 22.03nm, 0.281 and -1.20Mv respectively. Morphology was found to in spherical shape with the size range of 10-40 nm. In-vitro studies showed that formulation F4 has better release of 90.09% compared to drug in solution of 39.62%. F4, F5, F6 and F9 formulations were selected and converted into Liquisolid compacts using adsorbents Neuslin and Fuji calin and total eight formulations were formulated and Liquisolid compacts made of formulation F4 of Neuslin was found to be better release of 93.53% compared to formulation F4 of Fuji calin. Hence from our study it showed that Neuslin showed better drug release than Fuji Calin and Neuslin can be used to improve solubility and dissolution of poorly water soluble drugs.
Keywords: Resveratrol, Self-nanoemulsifying drug delivery systems, Liquisolid compacts, Characterization, Neuslin, Fuji calin.
Keywords:
Resveratrol, Self-nanoemulsifying drug delivery systems, Liquisolid compacts, Characterization, Neuslin, Fuji calinDOI
https://doi.org/10.22270/jddt.v12i6-S.5707References
Gowthamarajan K, Sachin KS. Dissolution testing for poorly soluble drugs: a continuing perspective. Dissolut Technol 2010; 24-32. https://doi.org/10.14227/DT170310P24
Tang H, Xiang S, Li X, Zhou J, Kuang C. Preparation and in vitro performance evaluation of resveratrol for oral self-microemulsion. PLoS One. 2019; 14(4):e0214544. https://doi.org/10.1371/journal.pone.0214544
Ma L, Li W, Wang R, Nan Y, Wang Q, Liu W, et al. Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis. Int J Oncol. 2015; 47(4):1460-1468. https://doi.org/10.3892/ijo.2015.3124
Vancauwenberghe E, Noyer L, Derouiche S, Lemonnier L, Gosset P, Sadofsky LR, et al. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF). Molecular Carcinogenesis. 2017; 56(8):1851-1867. https://doi.org/10.1002/mc.22642
Selvaraj S, Mohan A, Narayanan S, Sethuraman S, Krishnan UM. Dose-dependent interaction of transresveratrol with biomembranes: effects on antioxidant property. J Med Chem. 2013; 56(3):970-981. https://doi.org/10.1021/jm3014579
Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJ. Potential of resveratrol in anticancer and antiinflammatory therapy. Nutrition Reviews. 2010; 66(8):445-454. https://doi.org/10.1111/j.1753-4887.2008.00076.x
Yang YJ, Hu L, Xia YP, Jiang CY, Miao C, Yang CQ, et al. Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK. Journal of Neuroinflammation. 2016; 13(1):84-97. https://doi.org/10.1186/s12974-016-0550-6
Cui S, Zhao C, Chen D, He Z. Self-Microemulsifying Drug Delivery Systems (SMEDDS) for Improving In Vitro Dissolution and Oral Absorption of Pueraria Lobata Isoflavone. Drug Development & Industrial Pharmacy. 2005; 31(4-5):349-356. https://doi.org/10.1081/DDC-54309
Pineros I, Slowing K, Serrano DR, Pablo ED, Ballesteros MP. Analgesic and anti-inflammatory controlled-released injectable microemulsion: Pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation. European Journal of Pharmaceutical Sciences. 2017; 101:220-227. https://doi.org/10.1016/j.ejps.2016.12.030
Chen Y, Zhang H, Yang J, Sun H. Improved Antioxidant Capacity of Optimization of a Self-Microemulsifying Drug Delivery System for Resveratrol. Molecules. 2015; 20(12):21167-21177. https://doi.org/10.3390/molecules201219750
Maurya SD, Arya RKK, Rajpal G, Dhakar RC, Self-micro emulsifying drug delivery systems (SMEDDS): a review on physico-chemical and biopharmaceutical aspects, Journal of Drug Delivery and Therapeutics 2017; 7(3):55-65 https://doi.org/10.22270/jddt.v7i3.1453
Guo R, Guo X, Hu X, Abbasi AM, Zhou L, Li T, et al. Fabrication and Optimization of Self-Microemulsions to Improve the Oral Bioavailability of Total Flavones of Hippophae¨ rhamnoides L. J Food Sci. 2017; 82(12):2901-2909. https://doi.org/10.1111/1750-3841.13944
Wu X, Xu J, Huang X, Wen C. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Development & Industrial Pharmacy. 2011; 37(1):15-23. https://doi.org/10.3109/03639045.2010.489560
Jassim ZE. Formulation and evaluation of furosemide liquisolid compact. Int J Appl Pharm. 2017; 9(6):39-48. https://doi.org/10.22159/ijap.2017v9i6.21458
Anil AN, Thomas LI, Sudheer PR. Liquisolid compacts: an innovative approach for dissolution enhancement. Int J Pharm Pharm Sci. 2018; 10(6):11-7. https://doi.org/10.22159/ijpps.2018v10i6.25500
Javadzadeh Y, Siahi Shadbad MR, Barzegar Jalali M, Nokhodchi A. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Farmaco. 2005; 60(4):361-5. https://doi.org/10.1016/j.farmac.2004.09.005
Rokade MA, Khandagale PR, Phadtare DI. Liquisolid compact techniques: a review. Int J Curr Pharm Sci. 2018; 10(4):1-5. https://doi.org/10.22159/ijcpr.2018v10i4.28465
Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm. 2009; 73(3):373-84. https://doi.org/10.1016/j.ejpb.2009.08.002
Jain P, Nair S, Jain N, Jain DK, Jain S. Formulation and evaluation of solid dispersion of lomefloxacin hydrochloride. International Journal of Research in Pharmaceutical Sciences. 2012; 3(4):604-608.
Pandey SP, Khan MA, Dhote V, Dhote K, Jain DK. Formulation development of sustained release matrix tablet containing metformin hydrochloride and study of various factors affecting dissolution rate. Scholars Academic Journal of Pharmacy. 2019; 8(3):57-73.
Patel AK, Rai JP, Jain DK, Banweer JI. Formulation, development and evaluation of cefaclor extended release matrix tablet. International Journal of Pharmacy and Pharmaceutical Sciences. 2012; 4(4):355-7.
Gautam SP, Rai JP, Billshaiya U, Jain N, Vikram P, Jain DK. Formulation and evaluation of mouth dissolving tablet of loperamide. International Journal of Pharmaceutical Sciences and Research. 2013; 4(5):1782.
Published
Abstract Display: 437 
PDF Downloads: 533 PDF Downloads: 92 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.